We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent syringe - TGA Drug Approval Details
Approvals/TGA/ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent syringe
Approved
STANDARD
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent syringe
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5mL bivalent vaccine powder for injection vial and diluent syringe
Artg Id
406624
Artg Name
ABRYSVO recombinant respiratory syncytial virus pre-fusion F protein 120 microgram/0.5 mL bivalent vaccine powder for injection vial + diluent syringe
